RTL

KRTL Biotech Inc. is a diversified biotechnology and pharmaceutical company focused on the development, manufacturing, and global commercialization of essential medicines and innovative healthcare solutions. As a subsidiary of the publicly traded KRTL Holding Group, the company operates through a network of strategic partnerships and international mergers, most notably its recent integration with Sigma Corp (Bolivia) to scale its manufacturing capacity and product reach. KRTL Biotech maintains a robust portfolio of anti-infectives, antibiotics, and ophthalmic products, while also providing specialized regulatory consulting and market access services. The company is strategically positioned to enter the U.S. Active Pharmaceutical Ingredient (API) market, leveraging its FDA-compliant supply chains and Good Manufacturing Practice (GMP) certified facilities to address unmet public health needs in both developed and emerging markets.